Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home About Us
In the News

October 10, 2014
Bioniche Life Sciences Inc. to Publish Comprehensive Phase 3 Clinical Trial Results In The Journal of Urology

September 29, 2014
Bioniche Life Sciences Inc. Reports Fiscal 2014 Year-End Results


Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

About Us

Bioniche Life Sciences Inc. is a leading clinical stage biotechnology company focused on the development, manufacturing, and commercialization of proprietary and innovative therapeutics for the global human health market. The Company’s anchor product is in Phase III clinical development to treat non-muscle-invasive bladder cancer. The Company is exploring line extensions for its core technology and is actively seeking to add new and innovative development programs to its pipeline.

The Company is publicly traded on the Toronto Stock Exchange (TSX: BNC).

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy